Combination of eosinophil percentage and high‐sensitivity C‐reactive protein predicts in‐hospital major adverse cardiac events in ST‐elevation myocardial infarction patients undergoing primary percutaneous coronary intervention

BACKGROUND: Eosinophil levels predict prognosis in ST‐segment elevation myocardial infarction (STEMI) patients. Both eosinophils and high‐sensitivity C‐reactive protein (hs‐CRP) play a major role in the acute inflammatory response of myocardial infarction. The purpose of this study was to evaluate eosinophil percentage (EOS%) and hs‐CRP as prognostic markers for in‐hospital adverse events in STEMI patients undergoing primary percutaneous coronary intervention. METHODS: We retrospectively analyzed the clinical data of 518 patients. Major adverse cardiac events (MACEs) were defined as cardiac rupture, cardiac arrest, malignant arrhythmia, and cardiac death. Based on the receiver operating characteristic (ROC) analysis, all patients were regrouped into 3 groups (None, One, and Two) according to cutoff EOS% value (≤0.3%) and hs‐CRP value (>11.8 mg/L). Both Cox regression analyses and the KM (Kaplan‐Meier) survival curve were used to examine the prognostic role of combined hs‐CRP and EOS% in cardiovascular events. RESULTS: Of the 518 STEMI patients, 50 of them developed MACEs. Patients who developed MACEs had a significantly lower EOS% and higher hs‐CRP than patients who remained MACE‐free. In the multivariable Cox regression analysis, the highest risk of in‐hospital MACEs was constantly observed in patients with a combined low EOS% and elevated hs‐CRP. Patients with reduced EOS% and high hs‐CRP had significantly higher incidence rates of cardiac rupture (P = .001), cardiac arrest (P = .001), and malignant arrhythmia (P < .001); furthermore, they had the worst cumulative survival compared with the other two groups. CONCLUSION: Combined reduced EOS% and elevated hs‐CRP were valuable tools for identifying patients at risk of in‐hospital MACEs.